Co‐targeting <scp>BET</scp> and <scp>MEK</scp> as salvage therapy for <scp>MAPK</scp> and checkpoint inhibitor‐resistant melanoma
2018 · EMBO Molecular Medicine · 92 citations
https://doi.org/10.15252/emmm.201708446
P
Patricia Reyes-Uribe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
387
Citations
6
h-index
5
i10-index
Patricia Reyes-Uribe is an academic researcher from The Wistar Institute. The author has contributed to research in topics: Melanoma and MAPK Pathways & Protein Degradation and Inhibitors & Cutaneous Melanoma Detection and Management. The author has an h-index of 6, co-authored 12 publications.
Papers by this author
worksExploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
2018 · Oncogene · 53 citations
https://doi.org/10.1038/s41388-018-0247-7
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor–resistant <i>NRAS</i> -mutant melanoma
2025 · Science Translational Medicine · 2 citations
https://doi.org/10.1126/scitranslmed.adp8913
Figure 6
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5833797
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat